연구성과로 돌아가기
2023 연구성과별 연구자 정보 (1323 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Skarbnik, Alan P. | Skarbnik, AP | 6 | Novant Hlth Canc Inst, Charlotte, NC USA | dmiklos@stanford.edu; | |||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Yakoub-Agha, Ibrahim | Yakoub-Agha, I | 7 | Univ Lille, CHU Lille, INSERM U1286, Infinite, Lille, France | R-7872-2018 | Yakoub-Agha, Ibrahim | 0000-0003-4524-8782 | Yakoub-Agha, Ibrahim | dmiklos@stanford.edu; | |
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Ko, Bor-Sheng | Ko, BS | 8 | Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan | dmiklos@stanford.edu; | |||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Bruno, Benedetto | Bruno, B | 9 | K-1392-2018 | Bruno, Benedetto | 0000-0002-7299-6770 | Bruno, Benedetto | dmiklos@stanford.edu; | ||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Waller, Edmund K. | Waller, EK | 10 | AAP-3055-2020 | Waller, Edmund | 0000-0003-0816-6729 | Waller, Edmund K. | dmiklos@stanford.edu; | ||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Yared, Jean | Yared, J | 11 | dmiklos@stanford.edu; | ||||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Sohn, Sang Kyun | Sohn, SK | 12 | dmiklos@stanford.edu; | ||||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Bulabois, Claude-Eric | Bulabois, CE | 13 | dmiklos@stanford.edu; | ||||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Teshima, Takanori | Teshima, T | 14 | G-1671-2012 | teshima, takanori | dmiklos@stanford.edu; | ||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Jacobsohn, David | Jacobsohn, D | 15 | dmiklos@stanford.edu; | ||||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Greinix, Hildegard | Greinix, H | 16 | dmiklos@stanford.edu; | ||||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Mokatrin, Ahmad | Mokatrin, A | 17 | dmiklos@stanford.edu; | ||||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Lee, Yihua | Lee, YH | 18 | dmiklos@stanford.edu; | ||||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Wahlstrom, Justin T. | Wahlstrom, JT | 19 | dmiklos@stanford.edu; | ||||||
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Styles, Lori | Styles, L | 20 | dmiklos@stanford.edu; |
페이지 이동: